endpts.com·May 20, 2026
Pharmaceutical companies have seen a shift in their interactions with patients, largely due to the rise of direct-to-consumer channels and increased consumer demand for GLP-1 medications for weight loss.
The key insight for you is the increasing importance of direct-to-consumer channels in the pharmaceutical industry, particularly highlighted by the willingness of consumers to pay for GLP-1 medications for weight loss. This trend suggests potential opportunities for healthtech and biotech companies to innovate in patient engagement and monetization strategies, leveraging digital health platforms to enhance direct interaction with consumers.